Bliss GVS Pharma fundamental analysis

BLISSGVS

224.08

17.53 (8.49%)
Last updated on 25 Mar, 2026 | 15:56 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bliss GVS Pharma Fundamentals

P/E Ratio

20.02

P/B Ratio

1.89

Div. Yield

0.24

Sector P/E

58.66

Sector P/B

3.11

Sec. Div. Yield

0.6

Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 20.02, compared to the sector average of 58.66. Its P/B Ratio stands at 1.89, while the sector’s is 3.11. In terms of returns, the stock offers a Dividend Yield of 0.24%, which is than the sector’s 0.6%.

Bliss GVS Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Average

On its scorecard, Bliss GVS Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost